Antibody Recognition of the Pandemic H1N1 Influenza Virus Hemagglutinin Receptor Binding Site
about
Dynamic Viral Glycoprotein Machines: Approaches for Probing Transient States That Drive Membrane FusionStructural characterization of viral epitopes recognized by broadly cross-reactive antibodiesA common solution to group 2 influenza virus neutralizationReceptor mimicry by antibody F045–092 facilitates universal binding to the H3 subtype of influenza virusAlternative Recognition of the Conserved Stem Epitope in Influenza A Virus Hemagglutinin by a VH3-30-Encoded Heterosubtypic AntibodyConserved Neutralizing Epitope at Globular Head of Hemagglutinin in H3N2 Influenza VirusesAffinity maturation in an HIV broadly neutralizing B-cell lineage through reorientation of variable domainsPurification and immunogenicity of hemagglutinin from highly pathogenic avian influenza virus H5N1 expressed in Nicotiana benthamiana.Influenza hemagglutinin stem-fragment immunogen elicits broadly neutralizing antibodies and confers heterologous protectionIn silico structural homology modelling and docking for assessment of pandemic potential of a novel H7N9 influenza virus and its ability to be neutralized by existing anti-hemagglutinin antibodies.The Analysis of B-Cell Epitopes of Influenza Virus Hemagglutinin.Influenza immunization elicits antibodies specific for an egg-adapted vaccine strainCombination of the immunization with the sequence close to the consensus sequence and two DNA prime plus one VLP boost generate H5 hemagglutinin specific broad neutralizing antibodies.Characterization of a broadly neutralizing monoclonal antibody that targets the fusion domain of group 2 influenza A virus hemagglutinin.Structure of the apo anti-influenza CH65 Fab.Structural basis for Marburg virus neutralization by a cross-reactive human antibody.OptMAVEn--a new framework for the de novo design of antibody variable region models targeting specific antigen epitopes.Design and Structure of an Engineered Disulfide-Stabilized Influenza Virus Hemagglutinin Trimer.Isolation and Characterization of Broad and Ultrapotent Human Monoclonal Antibodies with Therapeutic Activity against Chikungunya Virus.Vaccine-elicited antibody that neutralizes H5N1 influenza and variants binds the receptor site and polymorphic sites.Improving Loop Modeling of the Antibody Complementarity-Determining Region 3 Using Knowledge-Based RestraintsFocused antibody response to influenza linked to antigenic driftStabilizing the CH2 Domain of an Antibody by Engineering in an Enhanced Aromatic SequonUse of computational and recombinant technologies for developing novel influenza vaccines.Heads, stalks and everything else: how can antibodies eradicate influenza as a human disease?A Perspective on the Structural and Functional Constraints for Immune Evasion: Insights from Influenza Virus.Comparison of the Protective Efficacy of Neutralizing Epitopes of 2009 Pandemic H1N1 Influenza Hemagglutinin.Principles of Broad and Potent Antiviral Human Antibodies: Insights for Vaccine Design.In vitro evolution of an influenza broadly neutralizing antibody is modulated by hemagglutinin receptor specificity.Viral receptor-binding site antibodies with diverse germline originsDiverse antigenic site targeting of influenza hemagglutinin in the murine antibody recall response to A(H1N1)pdm09 virus.Prospects of HA-based universal influenza vaccine.The bulky and the sweet: How neutralizing antibodies and glycan receptors compete for virus binding.Antibody 27F3 Broadly Targets Influenza A Group 1 and 2 Hemagglutinins through a Further Variation in VH1-69 Antibody Orientation on the HA Stem.Influenza A HA's conserved epitopes and broadly neutralizing antibodies: a prediction method.Structural insight into a human neutralizing antibody against influenza virus H7N9.Dissection of epitope-specific mechanisms of neutralization of influenza virus by intact IgG and Fab fragments.Structural insights into the design of novel anti-influenza therapies.An immuno-assay to quantify influenza virus hemagglutinin with correctly folded stalk domains in vaccine preparations.A small-molecule fragment that emulates binding of receptor and broadly neutralizing antibodies to influenza A hemagglutinin.
P2860
Q26772129-1F9C8494-03B6-44F7-9827-F9A5D305115BQ26823492-C505C471-065B-4504-8A5C-53F977178CE5Q27680873-3524CC2D-28AD-4A89-91F8-BE285EF425EAQ27683156-63DD9ADA-178B-46BD-B709-E64C15C7ABB1Q27683187-AB066AD5-5DCD-483B-A79C-27AD0E3FB01DQ27683198-DB396A44-63C1-4575-8D28-1324AB1A9A90Q27684503-6030D734-CA70-4134-9989-DDBA6C070693Q30151541-519F7416-221E-494B-BD20-F62848CBF149Q30209769-62E38D5B-B8C2-44DD-8BC0-D788742576C7Q30364943-F579D03B-2C7B-4FA4-818C-128F3C3F7049Q30387177-9D415E71-D303-4A44-9E6B-F90C434654B3Q30395005-8BFB0EC1-B2E9-482A-9E03-1688F87E3885Q33724743-CBBED129-581F-446B-9A0D-D6E551FFE82BQ34594065-D14E5F31-8D0B-4034-B856-68C08B2DBC0CQ35063209-F32CDC23-6D54-4A8D-9E9F-9D62672021AAQ35132751-D0E624DD-DE19-4A06-85B5-49ECE178A162Q35230802-4FAF9E7F-3098-40B5-9CD3-E2D931AB9822Q35758670-38670657-A2A5-4699-B763-913AC6D2C559Q35850197-D6505777-334D-4242-8E2F-C1B2F50C18A7Q35910153-43682A13-3483-4389-92E9-3E5A3DF4382DQ36018531-5F5EEE6D-792A-484A-9860-C761D0514140Q36184767-2E15F24A-4212-4C53-B10C-1588B6FB5462Q36855617-2C293C4C-551C-4E11-A8B1-0D0B3842CAC9Q38643466-8D421ABA-4A2E-44BE-9EF2-880975577E7CQ38804059-66BB32AB-25B5-495C-B6F9-C1B7D5469C1CQ39397313-03CB33CE-E970-4871-AD04-3A1CD9FF45A3Q40039860-716B11F4-29D1-4A82-8412-A67B48D38BC9Q40043685-B7F7E057-E16C-4229-B4CD-3B82CDF37A61Q40201534-25C0AB58-A43C-4161-B327-94BD84C1F81CQ40955071-C0DB3AE0-DB08-47BB-A881-88BA1EAC0F10Q41027323-3DB677F7-059D-4263-A345-3B5E9AFB2558Q41416400-C5E867C8-E5B3-417F-85D1-64A217D90ABBQ41922286-82E11766-5205-489F-829E-0E7371B59AFEQ41933744-AE65BD6D-77B3-4421-8312-5FC23F243D93Q42190242-933C9ED9-1F40-468C-9CBE-5D1B97AA695FQ45323700-C057FFBF-6473-4303-A569-341EAC2EFFF0Q47562645-1382F98C-7A8A-4E52-8A33-9646F2C9F1AAQ48113181-3FE2E1B6-9681-406C-A134-A00A39585490Q52607528-0947C9C8-8BE4-46CB-B892-9AC4021820E8Q52611914-6760750C-EF6A-43CC-BF69-531B7FABB711
P2860
Antibody Recognition of the Pandemic H1N1 Influenza Virus Hemagglutinin Receptor Binding Site
description
2013 nî lūn-bûn
@nan
2013 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Antibody Recognition of the Pa ...... glutinin Receptor Binding Site
@ast
Antibody Recognition of the Pa ...... glutinin Receptor Binding Site
@en
Antibody Recognition of the Pa ...... glutinin Receptor Binding Site
@nl
type
label
Antibody Recognition of the Pa ...... glutinin Receptor Binding Site
@ast
Antibody Recognition of the Pa ...... glutinin Receptor Binding Site
@en
Antibody Recognition of the Pa ...... glutinin Receptor Binding Site
@nl
prefLabel
Antibody Recognition of the Pa ...... glutinin Receptor Binding Site
@ast
Antibody Recognition of the Pa ...... glutinin Receptor Binding Site
@en
Antibody Recognition of the Pa ...... glutinin Receptor Binding Site
@nl
P2093
P2860
P3181
P356
P1433
P1476
Antibody Recognition of the Pa ...... glutinin Receptor Binding Site
@en
P2093
Andrew B Ward
Jens C Krause
Langzhou Song
Lynda Tussey
Minsun Hong
Nick S Laursen
Peter S Lee
Ryan M B Hoffman
Sung-Il Yoon
Xueyong Zhu
P2860
P304
P3181
P356
10.1128/JVI.01388-13
P577
2013-11-01T00:00:00Z